Senna Laxative Tablet
NDC Package 0761-0798-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Senna Laxative (sennosides) tablets is sennosides are used to treat constipation. This formulation utilizes a tablet delivery system. Marketed by Basic Drugs, Inc., this product is identified by NDC 0761-0798 and is authorized under FDA application 505G(a)(3).

Identification & Billing

NDC Package Code
0761-0798-02
Package Description
100 TABLET in 1 BOTTLE
Product Code
0761-0798
11-Digit Billing Format
00761079802
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Senna Laxative
Non-Proprietary Name
Sennosides
Substance Name
Sennosides
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
SENNOSIDES 8.6 mg/1
Usage Information
Sennosides are used to treat constipation. They may also be used to clean out the intestines before a bowel examination/surgery. Sennosides are known as stimulant laxatives. They work by keeping water in the intestines, which causes movement of the intestines.

Regulatory & Marketing

Labeler Name
Basic Drugs, Inc.
Product Type
Human Otc Drug
FDA Application #
505G(a)(3)
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-07-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0761-0798-02 identifies a specific commercial package of 100 tablet in 1 bottle of Senna Laxative, a human over the counter drug labeled by Basic Drugs, Inc.. This tablet is formulated for oral use and contains sennosides as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Basic Drugs, Inc. on May 07, 2024. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Sennosides are used to treat constipation. They may also be used to clean out the intestines before a bowel examination/surgery. Sennosides are known as stimulant laxatives. They work by keeping water in the intestines, which causes movement of the intestines.

How is this Basic Drugs, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00761079802. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0761-0798-02
11-Digit CMS (5-4-2)
00761-0798-02

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.